Hey BSD!
UCBA is very excited to offer a special edition of our annual speaker panel on Thursday, June 6th from 5:30-7 PM in GCIS W301/303. We will also be hosting a smaller dinner reception afterwards with our speakers at the Quadrangle Club from 7-9 PM.
For our annual speaker event, this year UCBA is partnering with the UChicago Medical and
Biological Sciences Alumni Association (MBSAA) to bring in alumni and hear their perspectives on career development following grad school. We will have a one hour panel discussion moderated by the UCBA board. Our panelists will be taking questions from the audience, as well as engaging with smaller groups of students in a more intimate dinner setting afterwards.
Limited dinner spots are available, so please fill out the survey on the Eventbrite
page to register for the dinner. Tickets to both portions of the event are required
and available first come first serve. See the Eventbrite page and info and flyer below for more details: https://www.eventbrite.com/e/insights-into-industry-with-mbsaa-tickets-62153359371
Do you have any specific interests or questions for the speakers to address? Please fill out our short survey here.
Speaker info:
Dr. Burrows is part of the Commercial Leadership Program at AbbVie. Burrows has marketing and commercial experience on multiple brands including Venclexta, Humira and other drugs. She received her PhD in 2015 from the Department of Human genetics here at UC and went on to get her MBA from Booth in 2017. During her tenure at UChicago, she was a Chicago Innovation Mentors Fellow, president of the UCBA, an Innovation Fund Associate and helped to create the myCHOICE program. During her MBA she helped to co-found a women’s health company, 4Women, which placed fifth in the New Venture Challenge.
Dr. Leventhal is currently working as a research and development scientist for Synlogic, a synthetic biology startup in Cambridge. AT Synlogic, Dr. Leventhal is working to create and evaluate human immune modulating strains of bacteria to treat cancer and auto immunity. Prior to Synlogic Dr. Leventhal was working as a scientist at Agenus where he helped to develop their cellular immunotherapy platform. Levelthal holds a degree in Cancer Biology from UChicago where he worked in the lab of Dr. Pete Savage. During his time at UC, Dr. Leventhal was heavily involved in UCBA, Chicago Innovation Mentors and myCHOICE.
As chief medical officer of Boston based Stoke Therapeutics, Dr. Tcho is responsible for Stokes efforts to develop therapeutics to treat orphan diseases. Prior to joining Stoke, Dr. Ticho was head of development of mRNA treatments at Moderna Therapeutics. He was previously lead of external R&D for cardiovascular and metabolic diseases at Pfizer, and prior to that held a senior position at Biogen. Ticho holds a MD from UChicago and completed his medical training at Northwestern and Children’s Hospital in Boston.
